The Journal of Hip Surgery 2019; 03(01): 034-040
DOI: 10.1055/s-0039-1678743
Special Section Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Metastatic Disease, Myeloma, and Lymphoma Affecting the Hip

Arianna L. Gianakos
1  Department of Orthopaedic Surgery, Jersey City Medical Center - RWJBarnabas Health, Jersey City, New Jersey
,
Jay N. Patel
2  Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Morristown Medical Center – Atlantic Health System, Morristown, New Jersey
,
Justin M. Miller
1  Department of Orthopaedic Surgery, Jersey City Medical Center - RWJBarnabas Health, Jersey City, New Jersey
,
Laura Sonnylal
3  Department of Orthopaedic Surgery, Hackensack University Medical Center, Hackensack, New Jersey
,
James C. Wittig
2  Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Morristown Medical Center – Atlantic Health System, Morristown, New Jersey
› Author Affiliations
Further Information

Publication History

31 August 2018

06 November 2018

Publication Date:
15 February 2019 (online)

Abstract

The three most common causes for bony lesions in patients over 40 years of age are metastatic disease, multiple myeloma, and lymphoma. Oftentimes, these conditions have a predilection for the hip region. The authors present the incidence, characteristics, and treatment of metastatic disease, multiple myeloma, and lymphoma affecting the hip joint to help clinicians accurately diagnose and manage these conditions. They also present the senior author's technique of cemented long stem hemiarthroplasty for treating these conditions when they affect the proximal femur.